stars 1 stars 2 stars 3

Vera Platform by Bionabu gives sponsors and CROs clinical trial oversight they can show. In most studies, protocol deviations live in the EDC, in spreadsheets and in paper logs, and the same person reports, classifies and reconciles them. We built Vera to fix the process, not the data. Vera Deviate™: protocol deviation management software. The CRA creates the case, the clinical team reviews it, the sponsor decides, and the record is locked. Name, role and time on every decision. It reads your EDC exports, spreadsheets and paper logs and never writes back, so nothing changes for your sites. Live in 3–6 weeks. Vera Simulate™: stress-tests a protocol before first patient in, to find where deviations could come from, so Vera Deviate goes live configured. Built on our experience in pediatric trials, where visit burden and consent are hardest to get right. Vera Academy: role-based training for every team that touches deviations. Configured for studies across 100+ sites in 8 countries. Founded by Ina Burgstaller after 20+ years in clinical trials as a CRA, lead CRA and clinical project manager. Find your oversight gaps with the free 5-minute self-check, or book a walkthrough, at bionabu.com. Bionesty Ltd, trading as Bionabu.

BIONABU Questions

Ina Burgstaller is the Founder and CEO of BIONABU.

3 people are employed at BIONABU.

Top BIONABU Employees

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users